Eli Lilly Antibody Treatment Can Be Nursing Home 'Safety Net', Says Coronavirus Research VP
With coronavirus affecting the senior population particularly hard, pharmaceutical company, Eli Lilly, is developing an COVID-19 antibody treatment meant to protect aging senior, particularly those in assisted living facilities.